STAGE IIA BREAST CANCER
Clinical trials for STAGE IIA BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIA BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIA BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise in preventing breast cancer return
Disease control CompletedThis study looked at whether shutting down the ovaries (ovarian suppression) and adding a drug called exemestane could better prevent breast cancer from coming back in premenopausal women with hormone-sensitive breast cancer. Over 3,000 women who had surgery took either tamoxifen…
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug combo offers Surgery-Free option for elderly breast cancer patients
Disease control CompletedThis study tested a combination of two hormone-blocking drugs (fulvestrant and palbociclib) in 14 elderly patients with hormone-sensitive breast cancer who either could not undergo surgery due to frailty or chose not to have it. The goal was to see if this drug pair could control…
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
9-Day radiation shows promise for breast cancer patients
Disease control CompletedThis study tested a shorter, 9-day course of whole breast radiation for people with early-stage breast cancer (stages 0 to IIB). The goal was to see if this condensed treatment is safe and effective, while also looking at cosmetic results and quality of life. A total of 102 parti…
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated May 11, 2026 20:49 UTC